作为对性相关的有前途的治疗选择,伊弗梅克是一种有希望的治疗选择
Mohammad Amin Manavi1,2, Razieh Mohammad Jafari1,3, Hamed Shafaroodi1,3
1Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Epilepsia open
|November 25, 2024
概括
艾弗梅克丁在减少性症相关 (OAE) 患者的发作方面表现有前途. 这种抗寄生虫药物也可能减少神经炎症,这是OAE的一个关键因素,提供了潜在的新治疗途径.
科学领域:
- 被忽视的热带疾病
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 河病或河盲是一种寄生虫病,由河虫 (Onchocerca volvulus) 引起.
- 与瘤相关的 (OAE) 不成比例地影响流行地区的儿童和青少年.
- 神经炎症是OAE病变的一个重要因素.
研究的目的:
- 调查ivermectin作为治疗OAE的潜力.
- 在OAE的背景下探索ivermectin的抗和抗炎性质.
- 评估ivermectin在患有O. volvulus感染和的患者中的安全性和有效性.
主要方法:
- 审查现有的临床研究对艾弗梅克丁对OAE患者发作的影响.
- 对ivermectin的药理机制的分析,包括GABAergic调节和细胞因子抑制.
- 检查报告的副作用和与抗发作药物 (ASM) 的药物相互作用.
主要成果:
- 预先的研究表明,甲可以减少一些OAE患者的发作频率和强度.
- 艾弗梅克具有抗作用,并降低关键的促炎细胞因子 (TNF-α,IL-1β).
- 伊弗梅克显示出良好的安全性,没有报告与ASM的相互作用.
结论:
- 由于其抗寄生虫,抗和抗炎作用,伊弗麦克丁对OAE具有潜在的治疗选择.
- 需要进一步的随机对照试验来确认ivermectin的疗效和在OAE管理中的最佳使用.
- 在等待进一步的临床验证之前,可以将伊佛麦丁视为对OAE的有利一线治疗方法.
更多相关视频
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.0K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.2K
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
01:30Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
01:14Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
251
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
251
01:17Antiepileptic Drugs: Calcium Channel Blockers
320
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
320